文献速递创伤与烧伤呼吸衰竭与机械通气

成人钝性创伤评估中胸部X线的筛查效能:是否有效及漏诊了什么?

Screening performance of the chest X-ray in adult blunt trauma evaluation: Is it effective and what does it miss?
PubMed 文献 · Am J Emerg Med · 2021-06-19
一句话结论在成人钝性创伤中,单用胸部X线筛查胸部损伤效能差,对任何损伤敏感性仅45.3%,即使临床重大损伤也漏诊近四分之一。

该研究基于NEXUS胸部CT研究的前瞻性数据,纳入9家一级创伤中心、年龄大于14岁、同时接受胸部X线和胸部CT的钝性创伤患者4501例,以CT为参考标准,按专家预设分类将损伤分为临床重大或轻微。结果显示1496例(33.2%)存在损伤,其中256例(17%)为重大损伤;胸部X线漏诊818例(54.7%)的任何损伤,其中63例(7.7%)为重大损伤。对临床重大损伤,胸部X线敏感性75.4%、特异性86.2%、阴性预测值98.3%;对任何损伤,敏感性仅45.3%、特异性96.6%。结论认为,在不结合其他创伤筛查标准的情况下,单用胸部X线对钝性胸部损伤的筛查效能差。

要点

  • 在同时接受胸部X线和胸部CT的4501例钝性创伤患者中,胸部X线漏诊任何胸部损伤的比例达54.7%(818例),漏诊重大损伤63例(占漏诊的7.7%)。
  • 对临床重大损伤,胸部X线敏感性75.4%(95%CI 69.6-80.4%)、特异性86.2%(95%CI 85.1-87.2%)、阴性预测值98.3%(95%CI 97.9-98.6%)。
  • 对任何损伤,胸部X线敏感性仅45.3%(95%CI 42.8-47.9%),阴性预测值78%(95%CI 77.2-78.8%),筛查效能差。
  • 最常漏诊的重大损伤包括气胸(30/185,16.2%)、脊柱骨折(19/39,48.7%)和血胸(8/70,11.4%)。
  • 最常漏诊的轻微损伤包括肋骨骨折(381/836,45.6%)、肺挫伤(203/462,43.9%)和胸骨骨折(153/229,66.8%)。

适用人群与场景

  • 年龄大于14岁的成人钝性创伤患者,在9家一级创伤中心接受胸部影像学评估。
  • 本分析仅纳入同时接受了胸部X线和胸部CT的患者(4501例)。

诊断标准与关键阈值

  • 以胸部CT为参考标准,由预设专家小组分类将损伤分为临床重大或轻微。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 胸部X线可能漏诊临床重大损伤,包括气胸(漏诊率16.2%)、脊柱骨折(漏诊率48.7%)和血胸(漏诊率11.4%),需警惕。
  • 胸部X线对任何损伤的阴性预测值仅78%,阴性结果不能排除胸部损伤。

研究设计与关键结果

  • 研究类型为基于NEXUS胸部CT研究的前瞻性队列分析,纳入9家一级创伤中心、4501例同时接受胸部X线和胸部CT的钝性创伤患者。
  • 1496例(33.2%)存在胸部损伤,其中256例(17%)为临床重大损伤。
  • 胸部X线漏诊818例(54.7%)的任何损伤,其中63例(7.7%)为重大损伤。
  • 对临床重大损伤:敏感性75.4%(95%CI 69.6-80.4%)、特异性86.2%(95%CI 85.1-87.2%)、阴性预测值98.3%(95%CI 97.9-98.6%)、阳性预测值24.7%(95%CI 22.9-26.7%)。
  • 对任何损伤:敏感性45.3%(95%CI 42.8-47.9%)、特异性96.6%(95%CI 95.9-97.2%)、阴性预测值78%(95%CI 77.2-78.8%)、阳性预测值86.9%(95%CI 84.5-89.0%)。

证据类型、等级与局限

  • 证据类型为前瞻性队列研究(基于NEXUS胸部CT研究),原文未给出证据等级或推荐强度。
  • 局限性:原文未明确列出局限性;设计上为多中心前瞻性研究,但分析仅纳入同时接受CXR和CT的患者,可能存在选择偏倚。

对床旁实践的改变

  • 在成人钝性创伤评估中,不应单独依赖胸部X线作为胸部损伤的筛查工具,尤其不能以阴性结果排除重大损伤。
  • 对于临床怀疑胸部损伤但胸部X线阴性的患者,应考虑进一步行胸部CT评估。
  • 原文未提及其他创伤筛查标准的具体内容,仅指出不结合其他标准时CXR筛查效能差。

指南或共识出处

  • NEXUS Chest CT study

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Although chest x-ray (CXR) is often used as a screening tool for thoracic injury in adult blunt trauma assessment, its screening performance is unclear. Using chest CT as the referent standard, we sought to determine the screening performance of CXR for injury.

METHODS: We analyzed data from the NEXUS Chest CT study, in which we prospectively enrolled blunt trauma patients older than 14 years who received chest imaging as part of their evaluation at nine level I trauma centers. For this analysis, we included patients who had both CXR and chest CT. We used CT as the referent standard and categorized injuries as clinically major or minor according to an a priori expert panel classification.

RESULTS: Of 11,477 patients enrolled, 4501 had both CXR and chest CT; 1496 (33.2%) were found to have injury, of which 256 (17%) were classified as major injury. CXR missed injuries in 818 patients (54.7%), of which 63 (7.7%) were classified as major injuries. For injuries of major clinical significance, CXR had a sensitivity of 75.4% (95% confidence interval [CI] 69.6-80.4%), specificity of 86.2% (95% CI 85.1-87.2%), negative predictive value of 98.3 (95%CI 97.9-98.6%), and positive predictive value of 24.7 (95%CI 22.9-26.7%). For any injury CXR had a sensitivity of 45.3% (95% CI 42.8-47.9%), specificity of 96.6% (95% CI 95.9-97.2%), negative predictive value of 78% (95% CI 77.2-78.8%), and positive predictive value of 86.9% (95% CI 84.5-89.0%). The most common missed major injuries were pneumothorax (30/185; 16.2%), spinal fractures (19/39; 48.7%), and hemothorax (8/70; 11.4%). The most common missed minor injuries were rib fractures (381/836; 45.6%), pulmonary contusion (203/462; 43.9%), and sternal fractures (153/229; 66.8%).

CONCLUSIONS: When used alone, without other trauma screening criteria, CXR has poor screening performance for blunt thoracic injury.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Dillon DG, Rodriguez RM. Screening performance of the chest X-ray in adult blunt trauma evaluation: Is it effective and what does it miss? Am J Emerg Med. 2021. PMID: 34182276. doi:10.1016/j.ajem.2021.06.034

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。